InvestorsHub Logo
Followers 17
Posts 1103
Boards Moderated 0
Alias Born 04/07/2020

Re: None

Tuesday, 12/29/2020 4:19:52 PM

Tuesday, December 29, 2020 4:19:52 PM

Post# of 233193
Let's do a quick recap on what brought Leronlimab to a phase 2B/3 trial. The FDA looked at data presented by CytoDyn from eIND patients being treated for severe to critical covid-19. They were impressed enough seeing the results they granted the phase 3 trial bypassing the standard phase 1 and 2. Leronlimab hasn't changed it's going to show the same incredible results from the trial as it did the eIND patients and in a matter of days the whole world will see it. Don't blink
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News